Clade Therapeutics
Melissa Chin has worked in the research field since 2008. Melissa began their career as a Volunteer Assistant at the University of Massachusetts in 2008, and then moved on to become a Research Assistant I at Boston Children's Hospital. In 2011, they became a Research Assistant II at the Transplantation Research Center at Boston Children's Hospital/Harvard Medical School. In 2013, they moved to Constellation Pharmaceuticals as a Research Associate. In 2015, they joined Editas Medicine as a Senior Research Associate and was promoted to Principal Research Associate in 2021. Currently, they are a Principal Research Associate at Clade Therapeutics.
Melissa Chin attended the University of Massachusetts, where they earned a Bachelor of Science in Biology.
This person is not in any offices
Clade Therapeutics
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.